Keyphrases
90-day Mortality
16%
Adjusted Odds Ratio
30%
Amphotericin B
25%
Angiotensin-converting Enzyme 2 (ACE2)
16%
Anti-B Cell Therapy
16%
Bendamustine
16%
Candida
83%
Candidemia
83%
Central Nervous System
33%
Comorbidity
16%
Confidence Interval
30%
COVID-19
83%
Cryptococcal Infection
83%
Factors Predicting
83%
Flucytosine
25%
Hematological Malignancies
40%
High Concentration
16%
Immunocompromised Adults
50%
Immunocompromised Host
16%
Immunocompromised Patients
83%
Induction Therapy
25%
Infective Endocarditis
83%
Initial Diagnosis
16%
Mortality Outcomes
83%
Multivariable Cox Regression
16%
Nervous System Diseases
83%
Obinutuzumab
16%
Plaque Assay
16%
Positive Check
16%
Pregenomic RNA (pgRNA)
16%
QPCR Assay
16%
Quantitative PCR
83%
Risk Factors
100%
Rituximab
16%
RT-PCR Test
33%
SARS-CoV-2 Antigen
16%
SARS-CoV-2 PCR
16%
SARS-CoV-2 RT-PCR
33%
SARS-CoV-2 Transmission
16%
SARS-CoV-2 Virus
16%
Solid Organ Transplant
16%
Titer
16%
Transmembrane Protease Serine 2 (TMPRSS2)
16%
Treatment Outcome
83%
Vero
16%
Viral Culture
83%
Viral Methods
16%
Viral Shedding
16%
Viral Titer
33%
Virus
33%
Medicine and Dentistry
Amphotericin B
22%
Antifungal Therapy
7%
B Cell
10%
B-Cell Chronic Lymphocytic Leukemia
10%
Bendamustine
10%
Blood Culture
7%
Candidemia
83%
Cardiac Imaging
7%
Cell Culture
83%
Central Nervous System
45%
Central Nervous System Disease
83%
Chemotherapy
10%
Clinical Predictor
7%
Comorbidity
15%
Coronavirinae
10%
COVID-19
10%
Disease
83%
Disease Predisposition
7%
Echocardiography
7%
Endocarditis
7%
Fluconazole
7%
Flucytosine
22%
Hematologic Malignancy
28%
Immunocompromised Patient
83%
Infection
22%
Infective Endocarditis
83%
Lumbar Puncture
7%
MALT Lymphoma
10%
Meningitis
7%
Mortality
7%
Nasopharyngeal Swab
10%
Obinutuzumab
10%
Odds Ratio
30%
Plaque Assay
10%
Proportional Hazards Model
15%
Quantitative Reverse Transcription Polymerase Chain Reaction
10%
Reverse Transcription Polymerase Chain Reaction
83%
Rituximab
10%
Severe Acute Respiratory Syndrome Coronavirus 2
83%
Silo-Filler's Disease
7%
Survival Analysis
7%
Therapeutic Management
7%
Total Parenteral Nutrition
7%
Transplantation
10%
Valvular Heart Disease
7%
Venetoclax
10%
Viral Cell
83%
Virus RNA
10%
Virus Shedding
10%
